RecruitingNot ApplicableNCT07171060

Laplace Early Feasibility Study - Canada

Laplace Outside the US (OUS) Early Feasibility Study (EFS) Canada

Sponsor

Laplace Interventional, Inc

Enrollment

15 participants

Start Date

Jun 18, 2024

Study Type

INTERVENTIONAL

Conditions

Tricuspid Regurgitation

Summary

The objective of the study is to assess the safety and technical feasibility of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System

Eligibility

Min Age: 60 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Laplace TTVR System for people with tricuspid regurgitation. The study is currently recruiting participants at 1 location. People eligible for this study include aged 60 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.